Skip to main content
. 2022 Mar 13;10(3):666. doi: 10.3390/biomedicines10030666

Figure 1.

Figure 1

Immunoglobulin-free light chains (FLCs) in patients with type 2 diabetes and healthy controls (Adapted from [13]).